Wegovy 0.25 Mg Injection

Product Description

Wegovy 0.25mg FlexTouch is used along with a reduced-calorie diet and increased physical activity to help lower the risk of major heart-related events, such as heart attack, stroke, or cardiovascular death, in adults who have established heart disease and also have obesity or overweight. It is also prescribed for long-term weight management in adults and adolescents aged 12 years and older with obesity, and in adults with overweight who have a weight-related health condition. In addition, Wegovy 0.25mg FlexTouch is used to treat noncirrhotic nonalcoholic steatohepatitis (NASH) in adults who have moderate to advanced liver scarring.

Wegovy 0.25mg FlexTouch is administered as a once-weekly injection. It is generally injected under the skin in your abdomen, thigh, or upper arm. Get the injection on the same day each week, at a similar time, to maintain consistent levels in your body. Along with the treatment, maintain a healthy diet and exercise regularly for maximum benefits.

The most common side effects of Wegovy 0.25mg FlexTouch include nausea, vomiting, diarrhea, stomach pain, constipation, and headache. These symptoms often occur during the initial stage; however, they usually improve over time as your body adjusts to the medication. Eating smaller meals or avoiding heavy, fried foods may help ease symptoms like nausea or an upset stomach. If you experience severe or persistent side effects, consult your doctor for advice.

Before starting Wegovy 0.25mg FlexTouch, inform your doctor about any medical conditions you have, particularly a history of pancreatitis, eye problems caused by diabetes (diabetic retinopathy), thyroid cancer, or severe gastrointestinal problems. This medicine is not recommended for individuals with a personal or family history of medullary thyroid carcinoma or those with multiple endocrine neoplasia syndrome type 2 (MEN 2).

Additionally, discuss with your doctor if you are on medications for type 2 diabetes, such as insulin or sulfonylureas; combining Wegovy 0.25mg FlexTouch with these medications can increase the risk of low blood sugar levels (hypoglycemia). Your doctor may need to adjust your medicine dosage to ensure safe use.

How Does Wegovy 0.25 mg Injection Work?

Wegovy 0.25 mg Injection utilizes the active ingredient Semaglutide, which stimulates GLP-1 receptors. This mechanism suppresses appetite, promotes a feeling of fullness, and helps reduce overall calorie intake, thereby supporting weight reduction efforts in individuals struggling with obesity or excess weight.


Proper Usage and Administration

Wegovy must be administered subcutaneously, once weekly, as directed by a physician. Each pre-filled pen contains four doses, one per week. The injection should only be given in recommended areas such as the abdomen, thigh, or upper arm. Never freeze the solution and always store it in a refrigerator between 2C and 8C.


Key Benefits for Weight Management

Wegovy is specifically formulated for adults with obesity or overweight linked to at least one weight-related medical condition. It assists in achieving weight loss goals by decreasing appetite, supporting healthier eating habits, and potentially improving associated conditions such as type 2 diabetes, heart disease risk factors, or metabolic issues.